Biotech Review of the Year Issue 13 - out now!
We’re pleased to share the 13th edition of our Biotech Review of the Year, bringing together practical legal, regulatory and commercial...
Competition authorities in Europe target ‘killer acquisitions’ – what biotech companies need to know
This article is part of our Biotech Review of the Year - Issue 13 publication.
Competition authorities are increasingly targeting...
Changes announced to the UK FDI mandatory notification regime
The UK government announces changes to the mandatory notification regime under the National Security and Investment Act. What are the...
Podcast: Patenting trends in women’s health
In this episode of our Spotlight on Women's Health and Innovation podcast, Maria Ryan and Melissa Dix explore how patenting trends offer...
Chinese biotech and the shift in global pharma deals
The historical western approach of relying on internally-developed blockbuster drugs to drive growth is now under strain. Patent expiries...
As a free user, you can like posts.
To repost this post to your own Passle blog, you will need to upgrade your account.
For plans and pricing, please contact our sales team at sales@passle.net